-+ 0.00%
-+ 0.00%
-+ 0.00%

Stifel Maintains Hold on TransMedics Group, Raises Price Target to $80

Benzinga·06/18/2026 12:40:39
Listen to the news
Stifel analyst Tom Stephan maintains TransMedics Group (NASDAQ:TMDX) with a Hold and raises the price target from $75 to $80.